Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cancer

• Publication date

  2017-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.30771PMID 28486781PMCID PMC5526459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

  2021cited by this paper
• Recurrent TP53 missense mutation in cancer patients of Arab descent

  2017influential reference
• Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications

  2016cited by this paper
• Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.

  2015cited by this paper
• Functional Analysis of BARD1 Missense Variants in Homology‐Directed Repair of DNA Double Strand Breaks

  2015cited by this paper
• BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.

  2015cited by this paper
• Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil

  2014cited by this paper
• Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

  2014cited by this paper
• Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.

  2013influential reference
• Increased oxidative metabolism in the Li-Fraumeni syndrome.

  2013influential reference
• Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation

  2012influential reference
• Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon

  2012cited by this paper
• National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology

  2012cited by this paper
• ENIGMA—Evidence‐based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

  2012cited by this paper
• Accurate and exact CNV identification from targeted high-throughput sequence data

  2011cited by this paper
• Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

  2011cited by this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cited by this paper
• Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

  2010cited by this paper
• A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer

  2007cited by this paper
• Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation

  2004cited by this paper
• Familial risk factors for breast cancer among Arab women in Israel

  2002cited by this paper
• BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia.

  2002cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001cited by this paper
• Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions

  1999cited by this paper
• p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

  1998cited by this paper
• Inherited p53 gene mutations in breast cancer.

  1992cited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Pan-Cancer Exome-wide analysis of germline mutational patterns and pathways

  2025cites this paper
• The argument for screening programs in previvors with Li-Fraumeni syndrome

  2025cites this paper
• The TP53 tumor suppressor gene: From molecular biology to clinical investigations

  2025cites this paper
• Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant-is it too soon to draw conclusions?

  2025cites this paper
• Integrative Gene-Centric Analysis Reveals Cellular Pathways Associated with Heritable Breast Cancer Predisposition

  2025cites this paper
• Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis

  2025cites this paper
• TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers.

  2024cites this paper
• The Association of PTEN Gene Mutations with the Breast Cancer Risk: A Systematic Review and Meta-analysis

  2023cites this paper
• Hereditary breast and ovarian cancer – University Hospital of Split experiences

  2023cites this paper
• Exploring the Potential Mechanism of Capsicum against Breast Cancer Based on Network Pharmacology

  2023cites this paper
• Germline TP53 pathogenic variants and breast cancer: A narrative review.

  2023cites this paper
• Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis

  2022cites this paper
• Benign single-nucleotide polymorphisms in the coding region of TP53: finding the needles in a haystack of pathogenic variants.

  2022cites this paper
• Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine

  2022cites this paper
• Targeted Sequencing of Germline Breast Cancer Susceptibility Genes for Discovering Pathogenic/Likely Pathogenic Variants in the Jakarta Population

  2022cites this paper
• Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors

  2022cites this paper
• Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2‐negative individuals who had genetic testing in a large urban comprehensive cancer center

  2022cites this paper
• Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region

  2022cites this paper
• Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN.

  2021cites this paper
• 2020 William Allan Award introduction: Mary-Claire King.

  2021cites this paper
• Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast Cancer.

  2021cites this paper
• Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1

  2021cites this paper
• Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations

  2020cites this paper
• A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53

  2020cites this paper
• Statistical approaches for meta‐analysis of genetic mutation prevalence

  2020cites this paper
• Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco

  2020cites this paper
• Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers

  2020cites this paper
• Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers

  2020cites this paper
• BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan

  2020cites this paper
• A systematic review of the international prevalence of BRCA mutation in breast cancer

  2019cites this paper
• BRCA mutation screening and patterns among high-risk Lebanese subjects

  2019cites this paper
• CLEP_A_206949 543..561

  2019cites this paper
• The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients

  2019cites this paper
• Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer

  2019cites this paper
• BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes

  2018cites this paper
• Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan

  2018cites this paper
• Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility

  2018cites this paper
• Current review of TP53 pathogenic germline variants in breast cancer patients outside Li‐Fraumeni syndrome

  2018cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper